CAV2 Mouse monoclonal Antibody IgG2a
Fig1: Western blot analysis of caveolin-2 on human caveolin-2 recombinant protein using anti- caveolin-2 antibody at 1/1,000 dilution.
Fig2: Western blot analysis of caveolin-2 on HEK293 (1) and caveolin-2-hIgGFc transfected HEK293 (2) cell lysate using anti- caveolin-2
Fig3: Western blot analysis of caveolin-2 on different cell lysate using anti- caveolin-2 antibody at 1/1,000 dilution.
Positive control: Line1: A549 Line2: 3T3-L1 Line3: A431
Host Species; Species ReactivityMouse; Human
Application SummaryWB, IHC, FC
Purification; FormulationProA affinity purified; 1*TBS (pH7.4), 1%BSA, Preservative: 0.05% Sodium Azide.; Liquid form.
ALTnamesInterferon-induced, double-stranded RNA-activated protein kinase, Eukaryotic translation initiation factor 2-alpha kinase 2, Interferon-inducible RNA-dependent protein kinase, P1/eIF-2A protein kinase, Protein kinase RNA-activated, Tyrosine-protein kinase EIF2AK2, p68 kinase
BackgroundCaveolae (also known as plasmalemmal vesicles) are 50-100 nM flask-shaped membranes that represent a subcompartment of the plasma membrane. On the basis of morphological studies, caveolae have been implicated to function in the transcytosis of various macromolecules (including LDL) across capillary endothelial cells, uptake of small molecules via potocytosis and the compartmentalization of certain signaling molecules including G protein-coupled receptors. Three proteins, caveolin-1, caveolin-2 and caveolin-3, have been identified as principal components of caveolae (6-8). Two forms of caveolin-1, designated alpha and beta, share a distinct but overlapping cellular distribution and differ by an amino terminal 31 amino acid sequence which is absent from the beta isoform. Caveolin-1 shares 31% identity with caveolin-2 and 65% identity with caveolin-3 at the amino acid level. Functionally, the three proteins differ in their interactions with heterotrimeric G protein isoforms (6-8)(EM1706-33)